News
KMB Accelerates Growth Through Digital & Club Channel Expansion
Kimberly-Clark Corporation's KMB third-quarter fiscal 2025 performance underscores a pivotal shift in the company’s growth model, with digital and club channels emerging as the primary growth
Is it Wise to Retain Essex Property Stock in Your Portfolio for Now?
Essex Property Trust, Inc. ESS is well-positioned to gain from a robust property base in the West Coast market with several demand drivers. The high cost of home ownership is likely to continue
BOX's Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Shares Fall
Box BOX reported third-quarter fiscal 2026 non-GAAP earnings of 31 cents per share, which declined 31% year over year. The figure was in line with the Zacks Consensus Estimate.Total revenues of $301
BankUnited Hits 52-Week High: How Should You Play the Stock Now?
As optimism grows over additional interest rate cuts before the end of 2025, BankUnited Inc. BKU shares touched a 52-week high of $44.73 in yesterday’s trading session to finally close at $44.02. In
CRWS Upgraded to Outperform on Cost Reset, Valuation & Dividend Yield
Crown Crafts, Inc. CRWS, recently upgraded to an “Outperform” from “Neutral,” is leaning into a margin- and cash-flow reset as it works through a tariff-heavy cost environment and the post–Baby Boom
ADP Disappoints: -32K Private Sector Jobs Last Month
Wednesday, December 3, 2025This morning’s big market news comes from the monthly jobs report from Automatic Data Processing ADP. Headline private-sector payrolls came in at a negative -32K for
Hims & Hers Expands Care Scope as Prescription Platforms Evolve
The renowned health and wellness platform, Hims & Hers Health, Inc.’s HIMS, business model links virtual consultations directly to prescription access and home delivery. Customers meet with
Can Burlington Stores' Burlington 2.0 Strategy Deliver Real Upside?
Burlington Stores, Inc. BURL is advancing its Burlington 2.0 strategy, with a strong focus on enhanced merchandising tools, planning capabilities and supply chain efficiencies. This strategic shift
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system compared to radiofrequency ablation (RFA) for chronic low back pain
The Bulls Are Back—Why Qualcomm Stock Is Gaining Strength Again
Qualcomm Inc. (NASDAQ: QCOM) shares are back on firm footing in recent sessions after a dodgy run last month. The stock closed just above $168 on Monday, extending its bounce from last month’s
BOE Stress Test 2025: Have BCS, HSBC & Others Proved Resilience?
According to the Bank of England’s 2025 Stress Test results, the country’s biggest lenders are well-equipped to withstand a severe economic downturn. In one of the toughest hypothetical scenarios
ALAB Stock Soars 51% in the Past 6 Months: Should You Buy Now or Wait?
Astera Labs ALAB shares have surged 51.2% in the past six-month period, outperforming the broader Zacks Computer & Technology sector’s rise of 27.1% and the Zacks Internet - Software industry’s
Gitlab Shares Down Despite Q3 Earnings Beat, Revenues Up Y/Y
GitLab GTLB reported third-quarter fiscal 2026 non-GAAP earnings of 25 cents per share, beating the Zacks Consensus Estimate by 25%. The company reported earnings of 23 cents per share in the
LULU Q3 EPS Preview: Are Shares Stretched to the Downside Enough?
Lululemon Company Overview
Founded in 1998 and based in Vancouver, Canada, Lululemon Athletica Inc. (LULU) is a yoga-inspired athletic apparel company that designs, manufactures, and distributes
Best Momentum Stocks to Buy for Dec.3
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 3:
Kennametal Inc. KMT: This specialty materials company has a Zacks Rank #1 and
Can Opendoor's AI Home Assessments Drive Speed and Scale?
Opendoor Technologies Inc.’s OPEN turnaround under new CEO Kaz Nejatian hinges on one question: Can AI-powered home assessments materially accelerate transactions and restore scale? Early data from
Is Snowflake (SNOW) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
Cloud-based data provider Snowflake SNOW is set to report third-quarter earnings results on Wednesday after the closing bell. Snowflake, a Zacks Rank #3 (Hold), has handily outperformed the market
Digital Turbine's ODS Growth Fueled by Ad Demand: What's Next?
Digital Turbine’s APPS On Device Solutions (ODS) offerings have been at the core of simplifying how users discover and receive mobile apps and content through carrier and OEM partnerships. ODS
Powell Industries' Diversification Efforts Gain Traction: What Lies Ahead?
Powell Industries, Inc.’s POWL diversification efforts beyond its core oil, gas and petrochemical markets have enhanced its market share across the electric utility, light rail traction power and
The Zacks Analyst Blog Highlights Apple, Tesla, Micron Technology, Hamilton Beach Brands and Key Tronic
For Immediate Release
Chicago, IL – December 3, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Marvell Technology Q3 Earnings Beat Estimates, Revenues Rise Y/Y
Marvell Technology, Inc. MRVL came out with third-quarter fiscal 2026 earnings of 76 cents per share, beating the Zacks Consensus Estimate by 1.3%. The company reported earnings of 43 cents per
AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension
AstraZeneca AZN announced that the FDA has accepted its new drug application (NDA) for baxdrostat for treating hard-to-control hypertension.
The NDA is seeking approval of baxdrostat for treating
The Zacks Analyst Blog Highlights NVIDIA and Palantir Technologies
For Immediate Release
Chicago, IL – December 3, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and
Earnings Preview: Vail Resorts (MTN) Q1 Earnings Expected to Decline
The market expects Vail Resorts (MTN) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended October 2025. This widely-known consensus


